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The KCL027 human embryonic stem cell line was derived from an embryo donated for research that carried an
autosomal dominantmutation affecting one allele of theHTT gene encoding huntingtin (43 trinucleotide repeats;
21 for the normal allele). The ICM was isolated using laser microsurgery and plated on γ-irradiated human
foreskin ﬁbroblasts. Both the derivation and cell line propagation were performed in an animal product-free
environment. Pluripotent state and differentiation potential were conﬁrmed by in vitro and in vivo assays.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Resource table
Name of stem cell line KCL027
Institution King's College London, London UK
Derivation team Neli Kadeva, Victoria Wood, Glenda Cornwell, Stefano
Codognotto, Emma Stephenson
Contact person and
email
Dusko Ilic, email: dusko.ilic@kcl.ac.uk
Date archived/stock
date
May 25, 2011
Type of resource Biological reagent: cell line
Sub-type Human pluripotent stem cell line
Origin Human embryo
Key marker expression Pluripotent stem cell markers: NANOG, OCT4, TRA-1-60,
TRA-1-81, alkaline phosphatase (AP) activity
Authentication Identity and purity of line conﬁrmed
Link to related
literature
(direct URL links
and full references)
1) Ilic, D., Stephenson, E., Wood, V., Jacquet, L., Stevenson,
D., Petrova, A., Kadeva, N., Codognotto, S., Patel, H.,
Semple, M., Cornwell, G., Ogilvie, C., Braude, P., 2012.
Derivation and feeder-free propagation of human em-
bryonic stem cells under xeno-free conditions.
Cytotherapy. 14 (1), 122–128.
doi: 10.3109/14653249.2011.623692
http://www.ncbi.nlm.nih.gov/pubmed/22029654
2) Stephenson, E., Jacquet, L., Miere, C., Wood, V., Kadeva,
N., Cornwell, G., Codognotto, S., Dajani, Y., Braude, P.,
Ilic, D., 2012. Derivation and propagation of human
embryonic stem cell lines from frozen embryos in an
animal product-free environment. Nat. Protoc. 7 (7),
1366–1381.
doi: 10.1038/nprot.2012.080
http://www.ncbi.nlm.nih.gov/pubmed/22722371
3) Jacquet, L., Neueder, A., Földes, G., Karagiannis, P.,
Hobbs, C., Jolinon, N., Mioulane, M., Sakai, T., Harding,
S.E., Ilic, D., 2015. Three Huntington's disease speciﬁc
mutation-carrying human embryonic stem cell lines
have stable number of CAG repeats upon in vitro
differentiation into cardiomyocytes. PLoS One. 10(5),
e0126860.
http://www.ncbi.nlm.nih.gov/pubmed/25993131
Information in public
databases
KCL027 is a National Institutes of Health (NIH) registered
hESC line
NIH Registration Number: 0223
NIH Approval Number: NIHhESC-13-0223
http://grants.nih.gov/stem_cells/registry/current.htm?id=663
Ethics The hESC line KCL027 is derived under license from the UK
Human Fertilisation and Embryology Authority (research
license numbers: R0075 and R0133) and also has local
ethical approval
(UK National Health Service Research Ethics Committee
Reference: 06/Q0702/90).
Informed consent was obtained from all subjects and the
experiments conformed to the principles set out in the
WMA Declaration of Helsinki and the NIH Belmont Report.
No ﬁnancial inducements are offered for donation.
Resource details
Consent signed Jan 27, 2011
Embryo thawed May 04, 2011
UK Stem Cell Bank Deposit Approval Dec 01, 2011
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⁎ Corresponding author.
E-mail address: dusko.ilic@kcl.ac.uk (D. Ilic).
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Contents lists available at ScienceDirect
Stem Cell Research
j ourna l homepage: www.e lsev ie r .com/ locate /scr
Reference: SCSC11-47
Sex Male 46, XY
Grade Research
Disease status (Fig. 1) Mutation affecting one allele of the HTT gene
encoding huntingtin (~43 CAG repeats; 21
for the normal allele) associated with
Huntington's disease (Jacquet et al., 2015)
Karyotype (aCGH) Deletion in the chromosome 2q37.3
(242,930,599–242,948,040) × 1; known
polymorphic variant.
DNA ﬁngerprint Allele sizes (in bp) of 17 microsatellite
markers speciﬁc for chromosomes 13, 18 and
21 (Jacquet et al., 2015)
HLA typing HLA-1: 02,03; -B: 07,35, -C: 04,07; DRB1: 01;
DQB1: 05:01, 05:01/03
Viability testing Pass
Pluripotent markers
(immunostaining) (Fig. 2)
NANOG, OCT4, TRA-1-60, TRA-1-81, AP activity
(Jacquet et al., 2015)
Three germ layer differentiation
in vitro (immunostaining)
(Fig. 3)
Endoderm: AFP (α-fetoprotein); Ectoderm:
TUBB3 (tubulin, β3 class III); Mesoderm:
ACTA2 (actin, α2, smooth muscle) (Jacquet
et al., 2015)
Three germ layer differentiation
in vivo (teratomas) (Fig. 4)
Endoderm: AFP, GATA4. Ectoderm: TUBB3,
GFAP (glial ﬁbrillary acidic protein). Mesoderm:
DES (desmin), Alcian Blue and periodic
acid–Schiff (PAS)-stained cartilage (Jacquet
et al., 2015)
Targeted differentiation (Fig. 5) Cardiomyocytes: TNNT2 (cardiac troponin
T) immunostaining
Sibling lines available KCL028
We generated KCL027 research grade hESC line following protocols,
established previously (Ilic et al., 2012; Stephenson et al., 2012). The ex-
pression of the pluripotencymarkers was tested after freeze/thaw cycle
(Fig. 2; Jacquet et al., 2015). Differentiation potential into three germ
layers was veriﬁed in vitro (Figs. 3 and 5; Jacquet et al., 2015) and
in vivo (Fig. 4; Jacquet et al., 2015).
Materials and methods
Consenting process
We distribute Patient Information Sheet (PIS) and consent form to
the in vitro fertilization (IVF) patients if they opted to donate to research
embryos that were stored for 5 or 10 years. They mail signed consent
back to us and that might be months after the PIS and consent were
mailed to them. If in the meantime new versions of PIS/consent are im-
plemented, we do not send these to the patients or ask them to re-sign;
thewhole process is donewith the version thatwas given them initially.
The PIS/consent documents (PGD-V.8) were created on Jul. 01, 2010.
HFEA Code of Practice that was in effect at the time of document crea-
tion: Edition 8 — R.2 (http://www.hfea.gov.uk/2999.html). The donor
couple signed the consent on Jan. 12, 2011. HFEA Code of Practice that
was in effect at the time of donor signature: Edition 8 — R.2. HFEA
Code of Practice Edition 8 — R.2 was in effect: Apr. 07, 2010–Apr. 06,
2011.
Embryo culture and micromanipulation
Embryo culture and laser-assisted dissection of inner cell mass
(ICM) were carried out as previously described in details (Ilic et al.,
2012; Stephenson et al., 2012). The cellular area containing the ICM
was then washed and transferred to plates containing mitotically
inactivated human neonatal foreskin ﬁbroblasts (HFF).
Cell culture
ICM plated onmitotically inactivated HFF was cultured as described
(Ilic et al., 2012; Stephenson et al., 2012). TE cells were removed
mechanically from outgrowth (Ilic et al., 2007; Ilic et al., 2010). hESC
colonies were expanded and cryopreserved at the third passage.
Viability test
Straws with the earliest frozen passage (p.2–3) are thawed and new
colonies are counted three days later. These colonies are then expanded
up to passage 8, atwhich point cellswere part frozen and part subjected
to standard battery of tests (pluripotency markers, in vitro and in vivo
differentiation capability, genetics, sterility, mycoplasma).
Pluripotency markers
Pluripotencywas assessed using two different techniques: enzymat-
ic activity assay [alkaline phosphatase (AP) assay] and immunostaining
as described (Ilic et al., 2012; Stephenson et al., 2012).
Differentiation
Spontaneous differentiation into three germ layers was assessed
in vitro and in vivo (Jacquet et al., 2015). Targeted differentiation in
cardiomyocytes followed the protocols described earlier (Jacquet
et al., 2015; Laﬂamme et al., 2007).
Genotyping
DNA was extracted from hESC cultures using a Chemagen DNA
extraction robot according to the manufacturer's instructions. Ampliﬁ-
cation of polymorphic microsatellite markers was carried out as
described (Ilic et al., 2012). Allele sizes were recorded to give a unique
ﬁngerprint of each cell line.
Array comparative genomic hybridization (aCGH)
aCGH was performed as described in details (Ilic et al., 2012).
HLA typing
HLA-A, -B and -DRB1 typing was performed with a PCR sequence-
speciﬁc oligonucleotide probe (SSOP; Luminex, Austin, TX, USA)
Fig. 1.Genetic pedigree tree. The couple undergoing IVF had 12 embryos in this particular cycle. Three embryos were normal, whereas nine carried themutation inHTT andwere donated
for research. We derived hESC lines from two of them.
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hybridization protocol at the certiﬁed Clinical Transplantation Laborato-
ry, Guy's and St Thomas' NHS Foundation Trust and Serco Plc. (GSTS) Pa-
thology (Guy's Hospital, London, UK) as described (Jacquet et al., 2013).
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Fig. 2. Expression of pluripotency markers. Pluripotency is conﬁrmed by immunostaining (Oct4, Nanog, TRA-1-60, TRA-1-81) and alkaline phosphatase (AP) activity assay. Scale bar,
20 μm.
Fig. 3. Differentiation of three germ layers in vitro is conﬁrmed by detection of markers: smooth muscle actin (ACTA2, red) for mesoderm, β-III tubulin (TUBB3, red) for ectoderm andα-
fetoprotein (AFP, red) for endoderm. Nuclei are visualized with Hoechst 33342 (blue). Scale bar, 100 μm.
Fig. 4. Differentiation of three germ layers in vivo. Teratomas were encapsulated and did not invade surrounding tissue. Sections are counterstained with hematoxylin and eosin and
speciﬁc stains are brown (immunohistochemistry). Germ layer marker: DES for mesoderm, TUBB3 for ectoderm, and GATA4 for endoderm. Scale bars are 100 μm.
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Fig. 5. TNNT2 (green) immunostaining on day 30 of cardiac differentiation. Nuclei are
visualized with Hoechst 33342 (blue). Scale bar, 10 μm.
277L. Jacquet et al. / Stem Cell Research 16 (2016) 274–277
